Lynn Webster, MD, Executive Vice President of Scientific Affairs, recently presented his poster titled “A Review of the Primary and Secondary Outcomes From a Phase I Study Comparing the Respiratory Effects of Buprenorphine Buccal Film and Oral Oxycodone Hydrochloride Administration.”

A phase 1 randomized, double-blind, placebo-controlled, double-dummy crossover study was conducted to compare the effects of Buprenorphine Buccal Film (BBF) and oxycodone immediate-release (IR). The study focused on respiratory drive, pharmacokinetics, oxygen saturation, and pupillary-constricting effects. The review covers previously published data from the study, which included healthy men and women who self-identified as recreational opioid users but were not currently dependent on opioids.

You can watch the presentation or read the article below.